A hand-held fan blowing air on the face eased breathlessness in people with chronic obstructive pulmonary disease (COPD) during…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Female nurses who worked in operating rooms (ORs) for 15 years or more are up to 69% more likely to…
Researchers at the Centenary UTS Centre for Inflammation in Australia have been awarded grants to investigate potential therapeutics for…
The health-related quality of life of people with chronic obstructive pulmonary disease (COPD) living in Barcelona, Spain, is negatively…
Glenmark Pharmaceuticals has launched Tiogiva, a tiotropium bromide dry powder inhaler (DPI) for…
Pulmatrix will regain full rights to its portfolio of narrow spectrum kinase inhibitor (NSKI) medications,…
The inflammatory biomarkers FeNO and EOS can be used as indicators to distinguish people with…
After a review of current evidence by a panel of experts, the American Thoracic Society…
A study has found that fast response to noninvasive ventilation (NIV) following acute exacerbation…
Low-dose Morphine Improves Health in COPD Patients With Shortness of Breath, Phase 4 Trial Suggests
Regular, low-dose oral morphine led to significant health improvements in adults with advanced chronic…